Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewAI Medical Record Solution Provider Abridge Secures $150 Million in Series C FundingOn February 22, Abridge, a provider of AI medical record solutions, secured $150 million in Series C funding. The round was led by Lightspeed Venture Partners, with participation from new and existing investors, including co-lead investor Redpoint Ventures. The funds will be used to invest in further R&D to build foundational models, driving improvements in the company’s existing technology and the development of new products.AI Data Analytics Service Provider Reveleer Secures Over $65 Million in FinancingOn February 26, AI data analytics service provider Reveleer secured over $65 million in funding, led by Hercules Capital. This funding will accelerate innovation, enhance patient care, and provide the company with inorganic growth opportunities in value-based care technology. Reveleer will continue to expand its offerings for payers and providers, delivering the most comprehensive workflow, data, and analytics solutions available in the market.Medical Data Platform b.well Connected Health Raises $40 Million in Series C FundingOn February 26, b.well Connected Health, a medical data platform, secured $40 million in Series C funding led by Leavitt Equity Partners. The funds aim to place consumers at the center of healthcare actions through b.well's scalable platform, enhance the value of technology investments, and accelerate b.well’s mission to address healthcare fragmentation.Digital Transformation Service Provider in Life Sciences, Zhejiang Mingdu Intelligent Control Technology Co., Ltd., Completes Hundreds of Millions of CNY in Series C FinancingOn February 29, Zhejiang Mingdu Intelligent Control Technology Co., Ltd., a life sciences digital transformation service provider, completed a C-round financing worth hundreds of millions of yuan. The round was led by Shenzhen Capital Group, with additional investment from China Merchants Health, and Index Capital served as the exclusive financial advisor. Based on Pharma Industry 4.0, Mingdu provides end-to-end digital solutions and has served over 350 pharmaceutical clients. In the future, Mingdu will collaborate with global pharmaceutical companies to accelerate the progress of digital and intelligent transformation in the life sciences industry.Mental Health Solutions Provider Matter Neuroscience Secures $26 Million in FinancingOn February 27, mental health solutions provider Matter Neuroscience secured $26 million in funding, co-led by ARCH Venture Partners, Polaris Partners, and Exor Ventures. With the support of the new round of funding, Matter will continue to revolutionize the understanding and management of mental health through Matter Neuroscience, pioneering solutions for mental health disorders.Remote Patient Monitoring Platform HealthSnap Completes $25 Million Series B FinancingOn February 21, remote patient monitoring platform HealthSnap completed a $25 million Series B financing round. This round was led by金沙资本 (Gansu Capital). The new funds will be used to continue building its clinical team, accelerate product development to meet the growing market demand for home care, and begin constructing its AI-driven population health and analytics solutions.Carewell, a pharmaceutical e-commerce company, secures $24.7 million in Series B fundingOn February 22, Carewell, a pharmaceutical e-commerce company, secured $24.7 million in its Series B financing round, led by the principal of MBF Healthcare with participation from existing investors such as Sageview Capital and Headline. The funds will be utilized to further accelerate the company's mission of simplifying access to home healthcare products. Additionally, the company has hired several senior executives and plans to relocate its headquarters to Miami.Wearable Device Developer Aktiia Secures CHF 27 Million in FundingOn February 27, Aktiia SA., a wearable device developer, secured CHF 27 million in funding led by Redalpine. This strategic capital injection will accelerate Aktiia's mission to alleviate the global burden of hypertension by providing groundbreaking blood pressure management insights through AI-driven technology. Currently, over 60,000 customers and dozens of medical institutions are utilizing the technology.Fertility Clinic Network Platform Pozitivf Secures $20 Million in FinancingOn February 22, fertility clinic network platform Pozitivf secured $20 million in funding, with this round led by MonCap. The company plans to use the funds to accelerate its expansion in the Texas and other regional markets, allowing more people to access top-tier fertility medical services.Mental Health Virtual Clinic Blackbird Health Raises $17 Million in Series A FundingOn February 21, Blackbird Health, a virtual mental health clinic, raised $17 million.Million USD A-round financing, participated by Define Ventures, First Cressey Ventures, and GreyMatter. This round of financing brings the company's total amount to 23 million USD. The company plans to use these funds to expand access to its integrated technology-supported adolescent mental health model.Health Management Platform Provider Redi Health Secures $14 Million in Series B FundingOn February 28, Redi Health, a provider of health management platforms, secured $14 million in Series B funding. The round was led by Blue Heron Capital, with participation from North Coast Ventures, Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. Redi Health will use the proceeds to drive innovation, develop and launch new products, expand its unique network, and accelerate overall growth.Smart Elderly Care Service Provider Dingjia Medical Completes Tens of Millions of Yuan in Pre-A Round FinancingOn February 22, Dingjia Medical, a smart elderly care service provider, completed a Pre-A round of financing worth tens of millions of yuan. The investor was Wang Achan, founder of Xiamen Letalk Communications. The funds from this round will mainly be used for upgrading the digital health management platform, establishing a 24-hour cloud call platform, and developing rehabilitation robots.Mental Health Service Provider FamilyWell Health Raises $4.3 Million in Seed FundingOn February 27, mental health service provider FamilyWell Health secured $4.3 million in seed funding. The round was led by 406 Ventures. The funds will support the company’s expansion in England and across China. FamilyWell integrates comprehensive mental health services directly into obstetric practices, providing specialized support for depression, anxiety, and other perinatal mental health issues for pregnant and postpartum patients.Diabetes Assistant Developer Hedia Secures €3 Million in Seed FundingOn February 27, Hedia, the developer of the diabetes assistant, secured 3 million euros in seed funding from existing shareholders and angel investors. This funding will support the development of its diabetes assistant and the launch of a comprehensive diabetes management solution. Additionally, the company will collaborate with strategic partners in the field of chronic metabolic diseases to develop artificial intelligence algorithms and Software as a Medical Device (SaMD) solutions.02 Digital Health Industry Dynamics
AbbVie and Tentarix Biotherapeutics Launch CollaborationOn February 22, AbbVie and Tentarix BiotherapeuticsTentarix Biotherapeutics Announces Multi-Year Collaboration to Discover and Develop Multispecific Biotherapeutic Candidates with Conditionally Controlled Activity in Oncology and ImmunologyTentarix Biotherapeutics announced a multi-year collaboration to discover and develop multispecific biotherapeutic candidates with conditionally controlled activity in the fields of oncology and immunology. This collaboration will combine AbbVie’s expertise in oncology and immunology with Tentarix's proprietary Tentacles platform. Under the terms of the agreement, Tentarix will receive an upfront payment totaling $64 million for the two programs from AbbVie. AbbVie will gain exclusive options to fully acquire these programs after Tentarix nominates candidate drugs, paying an undisclosed additional fee for each program.Catug Biotechnology Co., Ltd. and 100Biotech Collaborate to Advance the Development of In Vivo CAR-T Nucleic Acid Drugs On February 19, Catug Biotechnology Co., Ltd. and 100Biotech announced the official signing of a strategic cooperation agreement. The two parties will engage in in-depth cooperation in the in vivo CAR-T field.Novo Nordisk's IL-21 Monoclonal Antibody Licensed to Almirall On February 19, Almirall announced that it had entered into an exclusive license agreement with Novo Nordisk for the rights to IL-21 monoclonal antibody NN-8828. Under this agreement, Almirall obtained global rights to develop and commercialize this monoclonal antibody in certain fields, including immune-inflammatory skin diseases.Biocytogen and Gilead Sciences Reach Multi-Target Antibody Collaboration On February 19, Biocytogen announced that it had entered into an antibody evaluation and selection agreement with Gilead Sciences. The agreement authorizes Gilead to utilize Biocytogen’s fully human antibody library, which has been developed for a wide range of drug targets, to evaluate antibodies for relevant targets. During the three-year nomination period, Gilead will nominate multiple targets of interest, assess the corresponding antibodies, and has the option to select specific antibodies for the development of therapeutic products on a global scale.03 Global Digital Health M&A OverviewTHL Acquires Agiliti for $2.5 BillionOn February 26, Agiliti, the leading company in the U.S. third-party medical equipment maintenance industry, announced that three years after its listing on the New York Stock Exchange, it had reached a merger agreement with its majority shareholder, the "King of Acquisitions" — Thomas H. Lee Partners (THL). A subsidiary of the latter will acquire Agiliti's shares for a total consideration of $2.5 billion (approximately RMB 18 billion). After the transaction is completed, Agiliti will be delisted and become a privatized company.Medline Canada Completes Acquisition of Sinclair DentalOn February 23, Medline Canada, a global leading manufacturer and distributor of healthcare products and equipment, announced the completion of its acquisition of Sinclair Dental, a Canadian dental supplies distributor, becoming the leader in Canada’s dental supply market. Sinclair Dental will operate independently, spearheading Medline Canada's dental business strategy.Gracell Completes Merger Agreement with AstraZenecaOn February 22, Gracell Biotechnologies announced the official completion of the previously announced merger agreement with AstraZeneca Group. Following the completion of the merger, Gracell Biotechnologies became a wholly-owned subsidiary of the parent company, and its American Depositary Shares (ADSs) will no longer be listed or traded on any stock exchange, including the Nasdaq Global Select Market. In the announcement, Gracell Biotechnologies also stated that it had submitted relevant applications to suspend the trading of its ADSs on Nasdaq starting from February 22, 2024 (New York time).Artery Network/Arterial Orange Industry Think Tank/China Renaissance/BGI Co-Win/Rock Health/Mobile Health News/FierceHealth, etc.
Compiled by: Zhang Qiankun
